US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
ALDX holding history
Aldeyra Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALDX overviewAll 13F holders of ALDXFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −554−100.0% | Sold out | Holders |
| Q3 2025 | 554 | $2.89K | <0.1% | −20,582−97.4% | Reduced | Holders |
| Q2 2025 | 21,136 | $81.0K | <0.1% | +21,112+87,966.7% | Added | Holders |
| Q1 2025 | 24 | $138 | <0.1% | +24 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −5,578−100.0% | Sold out | Holders |
| Q3 2024 | 5,578 | $30.1K | <0.1% | +5,578 | New | Holders |